Copyright Yardbarker
The Boston Red Sox have declined their end of a $12M mutual option for right-hander Liam Hendriks, reports Chris Cotillo of MassLive. The former closer will take a $2M buyout and return to free agency. The decision doesn’t come as a surprise, as Hendriks has hardly pitched over the past three years. In 2023, a battle with non-Hodgkin’s lymphoma kept him out of action for a while. He eventually won that battle and was declared cancer-free, only to require Tommy John surgery after just five innings pitched. He reached free agency going into 2024 and the Red Sox signed him to a two-year deal with a $10M guarantee. That took the form of a $2M salary in the first year, a $6M salary in the second, followed by the aforementioned option and buyout. The Sox knew they might not get any contributions from Hendriks in the first year but were hoping their investment would pay off in the second, with Hendriks ideally returning to his previous elite closer form. It didn’t work out that way. Hendriks missed the entire 2024 season and then elbow problems lingered into the following year. He spent most of 2025 on the injured list, only throwing 13 2/3 innings. He underwent ulnar nerve transposition surgery in September and has an uncertain timeline. Hendriks will presumably be focused on getting healthy for a while. He will celebrate his 37th birthday in February. He’ll be a candidate for another bounce back deal at some point, though the shape of that deal will depend upon his future health outlook.
